Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raynaud's phenomenon. An update.

J D Coffman1

  • 1Evans Memorial Department of Clinical Research, University Hospital, Boston University Medical Center, Mass. 02118.

Hypertension (Dallas, Tex. : 1979)
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug treatment of peripheral vascular disease.

Heart disease (Hagerstown, Md.)·2001
Same author

Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension.

Hypertension (Dallas, Tex. : 1979)·2000
Same author

Association of the expression of an SR-cyclophilin with myeloid cell differentiation.

Blood·1996
Same author

Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.

Vascular medicine (London, England)·1996
Same author

Atheromatous embolism.

Vascular medicine (London, England)·1996
Same author

Effects of endothelium-derived nitric oxide on skin and digital blood flow in humans.

The American journal of physiology·1994
Same journal

Brain Iron in Nucleus Accumbens and Cognitive Function in Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Hypertension Treatment Intentions: A Health Belief Model Analysis.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Changes in Retinal Microvasculature During Healthy Pregnancy Measured by AO.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Longitudinal Maternal IgG and IgA Glycosylation Profiles in Pregnancy Reveal Early Immune Alterations in Placenta-Related Complications: The Rotterdam Periconception Cohort.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Blood Pressure Variability and Outcomes Across Antihypertensive Regimens.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Rural Health and Health Disparities in Hypertension Management: A Scientific Statement From the American Heart Association.

Hypertension (Dallas, Tex. : 1979)·2026
See all related articles

Primary Raynaud's phenomenon likely involves local digital artery abnormalities, particularly alpha 2-adrenergic receptor dysfunction. Current treatments include calcium channel blockers and lifestyle changes, with ongoing research into new therapies.

Area of Science:

  • Vascular Medicine
  • Pharmacology
  • Physiology

Background:

  • The exact cause of primary Raynaud's phenomenon is unknown.
  • Evidence suggests a local digital artery issue rather than sympathetic nervous system overactivity.
  • Alpha 2-adrenergic receptors are implicated due to their role in vasoconstriction.

Purpose of the Study:

  • To explore the underlying mechanisms of primary Raynaud's phenomenon.
  • To review diagnostic criteria and current treatment strategies.
  • To discuss emerging therapeutic options.

Main Methods:

  • Review of existing literature on Raynaud's phenomenon.
  • Analysis of the role of alpha 2-adrenergic receptors and serotonin.
  • Comparison of primary and secondary Raynaud's phenomenon characteristics.

Related Experiment Videos

Main Results:

  • Increased sensitivity and levels of alpha 2-adrenergic receptors in primary Raynaud's.
  • Serotonin's role is less clear.
  • Secondary Raynaud's can be linked to arterial pressure, vessel wall thickness, or beta-adrenergic activity.

Conclusions:

  • Primary Raynaud's phenomenon pathogenesis may involve alpha 2-adrenergic receptor abnormalities.
  • Diagnosis relies on clinical history, physical exam, and specific tests.
  • Nifedipine and sympatholytic agents are effective in two-thirds of patients; new therapies are under investigation.